ライフサイエンスコーパス: Mycoplasma pneumoniae

1 ens (2 with Ehrlichia chaffeensis and 1 with Mycoplasma pneumoniae).

2 of these differences by analysing RuvA from Mycoplasma pneumoniae.

3 rat and human SP-D with the human pathogen, Mycoplasma pneumoniae.

4 m 8% for Methanococcus jannaschii to 37% for Mycoplasma pneumoniae.

5 tococcus pneumoniae, Legionella species, and Mycoplasma pneumoniae.

6 ld-type copies, including the ruvA gene from Mycoplasma pneumoniae.

7 is (MLVA) method for the molecular typing of Mycoplasma pneumoniae.

8 oplasma genitalium and its closest relative, Mycoplasma pneumoniae.

9 ted B/C proteins (P90/P40), respectively, in Mycoplasma pneumoniae.

10 al organelle of the cell wall-less bacterium Mycoplasma pneumoniae.

11 8; coronavirus, 7; parainfluenza virus 4, 4; Mycoplasma pneumoniae, 1).

12 genitalium (26.3%) and the P1 cytadhesin of Mycoplasma pneumoniae (28.7%).

13 micdadei, 9 and 80 CFU/ml, respectively; for Mycoplasma pneumoniae, 5 CFU/ml; and for Chlamydia (Chla

14 The wall-less prokaryote Mycoplasma pneumoniae, a common cause of chronic respira

15 e increased inflammatory response induced by Mycoplasma pneumoniae, a pathogen known to exacerbate as

16 ccus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae accounting for most identified bac

17 Mycoplasma pneumoniae accounts for 20 to 30% of all comm

18 Mycoplasma pneumoniae adherence to host cells is a multi

19 Mycoplasma pneumoniae adsorbs to host respiratory epithe

20 ypical bacteria Chlamydophila pneumoniae and Mycoplasma pneumoniae and asthma pathogenesis; however,

21 urine pneumococcal and legionella antigens, Mycoplasma pneumoniae and Chlamydia pneumoniae antibodie

22 We assessed the utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae to di

23 these processes in the pathogenic bacterium Mycoplasma pneumoniae and its close relatives have also

24 genes encoding the P30 adhesin (one UGA) of Mycoplasma pneumoniae and methionine sulfoxide reductase

25 Mice were infected with Mycoplasma pneumoniae and monitored for the synthesis an

26 Mycoplasma pneumoniae and Mycoplasma genitalium are clos

27 es with cytadhesin-related functions in both Mycoplasma pneumoniae and Mycoplasma genitalium.

28 mnose was detected in the d configuration in Mycoplasma pneumoniae and Mycoplasma pulmonis, and in bo

29 llin-resistant Staphylococcus aureus (MRSA), Mycoplasma pneumoniae , and Candida albicans .

30 sciscella tularensis, Ehrlichia chaffeensis, Mycoplasma pneumoniae, and Escherichia coli, although ot

31 s, and marginally in Haemophilus influenzae, Mycoplasma pneumoniae, and Helicobacter pylori.

32 sthma inception, while Chlamydia pneumoniae, Mycoplasma pneumoniae, and latent adenovirus infections

33 the cytadherence-associated protein P65 from Mycoplasma pneumoniae, and MGA_0928, the M. gallisepticu

34 species representing the Mycoplasma hominis, Mycoplasma pneumoniae, and Spiroplasma phylogenetic clus

35 The cell wall-less prokaryote Mycoplasma pneumoniae approaches the minimal requirement

36 Atypical pathogens (notably mycoplasma pneumoniae) are now known to cause a wide spe

37 n technology, was used to initially identify Mycoplasma pneumoniae as the causative agent in this out

38 Mycoplasma pneumoniae attachment to host cells requires

39 he smallest and simplest of all known cells, Mycoplasma pneumoniae builds a surprisingly large and co

40 Pathogens such as Mycoplasma pneumoniae can exacerbate airway inflammation

41 Mycoplasma pneumoniae causes acute and chronic respirato

42 The cell wall-less prokaryote Mycoplasma pneumoniae causes bronchitis and atypical pne

43 The cell wall-less prokaryote Mycoplasma pneumoniae causes tracheobronchitis and prima

44 espiratory syncytial virus A (RSV A), RSV B, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legione

45 as Bordetella pertussis pertussis toxin and Mycoplasma pneumoniae community-acquired respiratory dis

46 Mycoplasma pneumoniae continues to be a significant caus

47 Mycoplasma pneumoniae cytadherence is mediated by a spec

48 in gene MPN142 (orf6) was identified in the Mycoplasma pneumoniae cytadherence mutant III-4.

49 A new genetic locus associated with Mycoplasma pneumoniae cytadherence was previously identi

50 surface protein P65 is a constituent of the Mycoplasma pneumoniae cytoskeleton and is present at red

51 ays derived from distinct genomic regions of Mycoplasma pneumoniae during an outbreak.

52 e (82%) predictive values when compared with Mycoplasma pneumoniae enzyme-linked immunosorbent assay.

53 The genomic sequence of Mycoplasma pneumoniae establish this cell-wall-less prok

54 Mycoplasma pneumoniae exhibits a novel form of gliding m

55 e most closely related to the members of the Mycoplasma pneumoniae group.

56 Infection with Mycoplasma pneumoniae has been shown to exacerbate asthm

57 Mycoplasma pneumoniae has been shown to induce airway in

58 Mycoplasma pneumoniae has no cell wall but possesses a c

59 mucosal pathogens, Mycoplasma genitalium and Mycoplasma pneumoniae, has helped define the essential f

60 Family 2 lipoproteins of Mycoplasma pneumoniae have a conserved "mycoplasma lipop

61 tes known, and yet several species including Mycoplasma pneumoniae have a remarkably complex cellular

62 preceding respiratory tract infections with Mycoplasma pneumoniae have been reported in some cases,

63 rom patients involved in a large outbreak of Mycoplasma pneumoniae in a closed religious community in

64 -bp element present within the chromosome of Mycoplasma pneumoniae in at least 10 copies.

65 ectrum of neurologic disease attributable to Mycoplasma pneumoniae in children is incompletely unders

66 Studies on Mycoplasma pneumoniae in Thailand have focused on urban

67 that SP-A binds to and is bacteriostatic for Mycoplasma pneumoniae in vitro.

68 incidence of atypical bacteria LRIs (notably Mycoplasma pneumoniae) in children is now recognized.

69 ed the effects of different timing of airway Mycoplasma pneumoniae infection on bronchial hyperrespon

70 onic eosinophilic pneumonia complicated with Mycoplasma pneumoniae infection was diagnosed on the bas

71 To investigate the pathogenesis of acute Mycoplasma pneumoniae infection, BALB/c mice were anesth

72 principal laboratory method used to diagnose Mycoplasma pneumoniae infection.

73 Mycoplasma pneumoniae infections represent a major prima

74 ting human herpes virus (HHV1-HHV7), HEV, or Mycoplasma pneumoniae infections using throat swab virus

75 lung inflammatory responses to bacteria (eg, Mycoplasma pneumoniae) involved in lung disease exacerba

76 iratory distress syndrome (CARDS) toxin from Mycoplasma pneumoniae is a 591-amino-acid virulence fact

77 Mycoplasma pneumoniae is a bacterial pathogen of the hum

78 e of the cell wall-less pathogenic bacterium Mycoplasma pneumoniae is a complex structure involved in

79 Mycoplasma pneumoniae is a human pathogen causing respir

80 Mycoplasma pneumoniae is a human pathogen that resides i

81 Mycoplasma pneumoniae is a leading cause of community-ac

82 Mycoplasma pneumoniae is a leading cause of community-ac

83 Mycoplasma pneumoniae is a leading cause of pneumonia an

84 Mycoplasma pneumoniae is a leading cause of pneumonia an

85 Mycoplasma pneumoniae is a leading cause of respiratory

86 Mycoplasma pneumoniae is a major cause of bronchitis and

87 The cell wall-less prokaryote Mycoplasma pneumoniae is a major cause of community-acqu

88 Mycoplasma pneumoniae is a major cause of tracheobronchi

89 Mycoplasma pneumoniae is a major human respiratory patho

90 Mycoplasma pneumoniae is a minimal microbe with respect

91 The attachment organelle of Mycoplasma pneumoniae is a polar, tapered cell extension

92 Mycoplasma pneumoniae is a significant cause of pneumoni

93 Mycoplasma pneumoniae is a significant human respiratory

94 Mycoplasma pneumoniae is a small bacterium without a cel

95 Mycoplasma pneumoniae is a wall-less human respiratory t

96 Mycoplasma pneumoniae is an atypical bacterial respirato

97 Mycoplasma pneumoniae is an extracellular pathogen that

98 Mycoplasma pneumoniae is an important cause of respirato

99 Macrolide-resistant Mycoplasma pneumoniae is an increasing problem worldwide

100 Because Mycoplasma pneumoniae is hypothesized to play an importa

101 nducting airways of humans by the prokaryote Mycoplasma pneumoniae is mediated by a differentiated te

102 Unlike many bacterial pathogens, Mycoplasma pneumoniae is not known to produce classical

103 Mycoplasma pneumoniae is the leading cause of pneumonia

104 Mycoplasma pneumoniae, long appreciated as one of the tr

105 The cell-wall-less prokaryote Mycoplasma pneumoniae, long considered among the smalles

106 licobacter pylori, Methanococcus jannaschii, Mycoplasma pneumoniae, M. genitalium, and Synechocystis

107 t S. pneumoniae, or Chlamydia pneumoniae and Mycoplasma pneumoniae may facilitate the clinical manage

108 The terminal organelle of Mycoplasma pneumoniae mediates cytadherence and gliding

109 Mycoplasma pneumoniae (Mp) cytadherence requires the pro

110 Mycoplasma pneumoniae (Mp) frequently colonizes the airw

111 Outbreaks of Mycoplasma pneumoniae (MP) in closed communities can hav

112 Mycoplasma pneumoniae (Mp) infections cause tracheobronc

113 d recognition and degradation of an extended Mycoplasma pneumoniae (MP) tmRNA tag by the MP-Lon prote

114 Respiratory infections, including Mycoplasma pneumoniae (Mp), contribute to asthma pathobi

115 atory infections, such as atypical bacterium Mycoplasma pneumoniae (Mp), have been proposed to worsen

116 SP-A has a bacteriostatic effect on Mycoplasma pneumoniae (Mp), which occurs by binding surf

117 UNC1 in vitro antibacterial property against Mycoplasma pneumoniae (Mp).

118 athogens Staphylococcus aureus (SaEf-Tu) and Mycoplasma pneumoniae (MpnEf-Tu), and the porcine pathog

119 neous, hemadsorption-negative (HA-) class II Mycoplasma pneumoniae mutants that displayed P30 adhesin

120 mophilus influenzae, Neisseria meningitidis, Mycoplasma pneumoniae, Mycobacterium tuberculosis, and B

121 l of antimicrobial susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasm

122 A nested PCR specific for the Mycoplasma pneumoniae P1 gene was used to diagnose mycop

123 ned the structure of full length HPrK/P from Mycoplasma pneumoniae (PD8 ID, 1KNX) to 2.5A resolution.

124 Early distinction between severe Mycoplasma pneumoniae pneumonia (MPP) and mild MPP is st

125 no recommended epidemic-control measures for Mycoplasma pneumoniae pneumonia outbreaks in closed comm

126 Mycoplasma pneumoniae protein P200 was localized to the

127 Mycoplasma pneumoniae proteins HMW1-HMW3 collectively ar

128 t of detection was </=88 CFU/reaction for 10 Mycoplasma pneumoniae reference strains.

129 Because chronic Mycoplasma pneumoniae respiratory infection is hypothesi

130 Complete genome analysis of Mycoplasma pneumoniae revealed the presence of numerous

131 the bacterial species Mycoplasma genitalium, Mycoplasma pneumoniae, Shewanella putrefaciens, Synechoc

132 cell cultures infected with a PyNP-deficient Mycoplasma pneumoniae strain.

133 emophilus influenzae, Mycoplasma genitalium, Mycoplasma pneumoniae, Synechocystis sp. strain PCC6803,

134 ediatric patient secondary to infection with Mycoplasma pneumoniae that progressed to cardiac tampona

135 Laboratory tests showed Mycoplasma pneumoniae to be the etiological agent.

136 teins required for adherence of the pathogen Mycoplasma pneumoniae to host respiratory epithelial cel

137 six bacteria that have varied genome sizes (Mycoplasma pneumoniae, Treponema pallidum, Helicobacter

138 The presence of Chlamydophila pneumoniae or Mycoplasma pneumoniae was ascertained by serologic analy

139 Mycoplasma pneumoniae was detected in 1.9% of patients a

140 trongly conserved mycoplasmal 16S RNA genes, Mycoplasma pneumoniae was found in the synovial fluid of

141 Mycoplasma pneumoniae was more common among children 5 y

142 Chlamydia pneumoniae and Mycoplasma pneumoniae were evaluated as agents of persis

143 Mycoplasma pneumoniae, which causes primary atypical pne

144 herichia coli, Streptococcus pneumoniae, and Mycoplasma pneumoniae, which exemplify gram-negative, gr

145 ficant sequence homology to the ORF6 gene of Mycoplasma pneumoniae, which has been shown to play an a

146 identified two surface proteins of virulent Mycoplasma pneumoniae with molecular masses of 45 and 30

147 ly become available for Escherichia coli and Mycoplasma pneumoniae, yielding 443 and 116 heteromultim